Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keith S Kaye

Showing results (351-360 of 421) with videos related to

Pageof 43
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 12, 2017
Colistin Versus Ceftazidime-Avibactam in the Treatment of Infections Due to Carbapenem-Resistant EnterobacteriaceaeDavid van Duin, Judith J Lok, Michelle Earley, et al.
Infection Control and Hospital Epidemiology|July 16, 2019
Identification of four patients with colistin-resistant Escherichia coli containing the mobile colistin resistance mcr-1 gene from a single health system in MichiganOryan Henig, Laura J Rojas, Michael A Bachman, et al.
The European Respiratory Journal|May 11, 2023
Reply to: Anti-anaerobic antibiotics: indication is keyRishi Chanderraj, Jennifer M Baker, Stephen G Kay, et al.
Antimicrobial Agents and Chemotherapy|May 2, 2012
Impact of cefepime therapy on mortality among patients with bloodstream infections caused by extended-spectrum-β-lactamase-producing Klebsiella pneumoniae and Escherichia coliTeena Chopra, Dror Marchaim, Jennifer Veltman, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 1, 2024
Exebacase in Addition to Standard-of-Care Antibiotics for Staphylococcus aureus Bloodstream Infections and Right-Sided Infective Endocarditis: A Phase 3, Superiority-Design, Placebo-Controlled, Randomized Clinical Trial (DISRUPT)Vance G Fowler, Anita F Das, Joy Lipka-Diamond, et al.
Diagnostic Microbiology and Infectious Disease|February 20, 2018
Evaluation of Sensititre Broth Microdilution Plate for determining the susceptibility of carbapenem-resistant Klebsiella pneumoniae to polymyxinsSandra S Richter, James Karichu, Joshua Otiso, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 18, 2016
Risk of Acute Kidney Injury in Patients on Concomitant Vancomycin and Piperacillin-Tazobactam Compared to Those on Vancomycin and CefepimeBhagyashri Navalkele, Jason M Pogue, Shigehiko Karino, et al.
Open Forum Infectious Diseases|February 11, 2022
Multicenter Cohort Study of Ceftaroline Versus Daptomycin for Treatment of Methicillin-Resistant <i>Staphylococcus aureus</i> Bloodstream InfectionEvan J Zasowski, Trang D Trinh, Kimberly C Claeys, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 11, 2019
RESTORE-IMI 1: A Multicenter, Randomized, Double-blind Trial Comparing Efficacy and Safety of Imipenem/Relebactam vs Colistin Plus Imipenem in Patients With Imipenem-nonsusceptible Bacterial InfectionsJohann Motsch, Cláudia Murta de Oliveira, Viktor Stus, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 4, 2024
2024 Clinical Practice Guideline Update by the Infectious Diseases Society of America on Complicated Intra-abdominal Infections: Utility of Intra-abdominal Fluid Cultures in Adults, Children, and Pregnant PeopleRobert A Bonomo, Romney Humphries, Fredrick M Abrahamian, et al.
Pageof 43

Showing results (351-360 of 421) with videos related to

Sort By:
Pageof 43
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 12, 2017
Colistin Versus Ceftazidime-Avibactam in the Treatment of Infections Due to Carbapenem-Resistant EnterobacteriaceaeDavid van Duin, Judith J Lok, Michelle Earley, et al.
Infection Control and Hospital Epidemiology|July 16, 2019
Identification of four patients with colistin-resistant Escherichia coli containing the mobile colistin resistance mcr-1 gene from a single health system in MichiganOryan Henig, Laura J Rojas, Michael A Bachman, et al.
The European Respiratory Journal|May 11, 2023
Reply to: Anti-anaerobic antibiotics: indication is keyRishi Chanderraj, Jennifer M Baker, Stephen G Kay, et al.
Antimicrobial Agents and Chemotherapy|May 2, 2012
Impact of cefepime therapy on mortality among patients with bloodstream infections caused by extended-spectrum-β-lactamase-producing Klebsiella pneumoniae and Escherichia coliTeena Chopra, Dror Marchaim, Jennifer Veltman, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 1, 2024
Exebacase in Addition to Standard-of-Care Antibiotics for Staphylococcus aureus Bloodstream Infections and Right-Sided Infective Endocarditis: A Phase 3, Superiority-Design, Placebo-Controlled, Randomized Clinical Trial (DISRUPT)Vance G Fowler, Anita F Das, Joy Lipka-Diamond, et al.
Diagnostic Microbiology and Infectious Disease|February 20, 2018
Evaluation of Sensititre Broth Microdilution Plate for determining the susceptibility of carbapenem-resistant Klebsiella pneumoniae to polymyxinsSandra S Richter, James Karichu, Joshua Otiso, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 18, 2016
Risk of Acute Kidney Injury in Patients on Concomitant Vancomycin and Piperacillin-Tazobactam Compared to Those on Vancomycin and CefepimeBhagyashri Navalkele, Jason M Pogue, Shigehiko Karino, et al.
Open Forum Infectious Diseases|February 11, 2022
Multicenter Cohort Study of Ceftaroline Versus Daptomycin for Treatment of Methicillin-Resistant <i>Staphylococcus aureus</i> Bloodstream InfectionEvan J Zasowski, Trang D Trinh, Kimberly C Claeys, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 11, 2019
RESTORE-IMI 1: A Multicenter, Randomized, Double-blind Trial Comparing Efficacy and Safety of Imipenem/Relebactam vs Colistin Plus Imipenem in Patients With Imipenem-nonsusceptible Bacterial InfectionsJohann Motsch, Cláudia Murta de Oliveira, Viktor Stus, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 4, 2024
2024 Clinical Practice Guideline Update by the Infectious Diseases Society of America on Complicated Intra-abdominal Infections: Utility of Intra-abdominal Fluid Cultures in Adults, Children, and Pregnant PeopleRobert A Bonomo, Romney Humphries, Fredrick M Abrahamian, et al.
Pageof 43